about
Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysisComparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic.Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods.Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patientsDevelopment and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in womenHead-to-head evaluation of five chlamydia tests relative to a quality-assured culture standardMulticenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis.Diagnostic performance of the Roche AMPLICOR PCR in detecting Neisseria gonorrhoeae in genitourinary specimens from female sex workers in Cotonou, Benin.Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic menDetection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests.Evaluation of a modified sanitary napkin as a sample self-collection device for the detection of genital chlamydial infection in womenRelative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men.Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.Postal urine specimens: are they a feasible method for genital chlamydial infection screening?Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium.Evaluation of a new amplified enzyme immunoassay (EIA) for the detection of Chlamydia trachomatis in male urine, female endocervical swab, and patient obtained vaginal swab specimens.The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women.Detection of Chlamydia trachomatis in vaginal specimens from female commercial sex workers using a new improved enzyme immunoassay.Impact of menstrual cycle on the diagnostic performance of LCR, TMA, and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples.A new gold standard for the detection of Chlamydia trachomatis?Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populationsDiagnosis and assessment of trachoma.Genetic tests and their evaluation: can we answer the key questions?Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis.Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test.Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study.Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.Estimating diagnostic accuracy of multiple binary tests with an imperfect reference standardComparison of multiplex PCR assay with culture for detection of genital mycoplasmas.Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology.NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled.Methods and recommendations for evaluating and reporting a new diagnostic test.Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.Latent class analysis permits unbiased estimates of the validity of DAT for the diagnosis of visceral leishmaniasis.Discrepant analysis: how can we test a test?Comparison of IsoCode STIX and FTA Gene Guard collection matrices as whole-blood storage and processing devices for diagnosis of malaria by PCR.The US Food and Drug Administration perspective on cancer biomarker development.Evaluating qualitative assays using sensitivity and specificity.
P2860
Q33655768-180C67E8-D34F-40BB-B927-297EE130D7B4Q33668453-FEA430F8-77C2-492E-B5F9-4726F5178391Q33674686-5B02A689-120A-46D9-9F21-AA87D6303783Q33683069-F2147356-9BDF-4FCA-B8EB-9819A9DA7DE4Q33885194-735BF63C-04F5-4F6C-AED9-78DDBDB3B113Q33947022-319D7930-1A07-4DC7-BEDC-802DDA9B7D1CQ33959268-2543C592-6873-4382-A523-FDCF595F9398Q33966004-66BC54E3-A43F-43A7-B7AF-340B050978F3Q33970240-E3F4CC4B-0C9D-47CD-AB11-E971D499D6CAQ33970510-E5FD0BA2-32DC-4D41-ACD9-DBB89B96CF0EQ33972194-3D1A8FF0-27F8-4366-963B-E6FBA648C934Q33972866-84289098-FD81-4C9F-A723-FCB277A31F8EQ33973939-938D2EC8-66C2-4657-B6EB-381A44879214Q34200192-347862B6-B47E-4244-8B01-A934B38559E0Q34217028-04FFD9E0-5216-445D-ABD2-2244A508C88FQ34748499-92D47888-4D5D-4856-9948-2511C59FFF37Q34974306-447FF8F6-95C6-45E4-8477-14D4D1FF97C3Q35396386-E50F11E0-4CF5-4EC9-A2A8-36E3EFD6820CQ35562077-2A3583CA-CCB7-4434-9E35-576409C1837DQ35562314-D09AEF36-A77E-44BE-A6F1-8110D0977037Q35562541-A976E369-A78E-4AAD-AC18-301F0F5138EEQ35615380-B4E231D9-E721-4D7D-AAE8-ED15E6E432B1Q35716830-757F33A6-35E8-4F72-9236-1FE5722A79CDQ35920659-A0F3BA18-0B9C-4D7C-B1EB-D7AF0167670EQ35951362-E06D404F-CC36-478F-9FA7-0668374E44AEQ36422544-0281D973-3243-4637-8A00-7E503D64DDEDQ36544027-2B07BC86-7F3B-4015-8632-74E9BA1AF2F6Q36601065-BBBC384A-9DF3-4CED-89E2-F33E09D9582EQ36606759-A4D04C4C-C464-43F9-857C-5A4616C71A53Q37369559-60FDD055-21BB-4C21-8EC3-91588546DDE6Q37419674-FEF03974-9091-4F48-BDC8-8273AFDD7365Q37713244-42C3C309-9E8D-4082-85F7-9A7E5CA8154CQ37872321-0000A572-CD61-4A4F-9342-E91CF5626078Q38000035-1F78990B-C791-45BA-B333-0DDEE2361B5BQ38410826-92DE9707-44D3-48A4-A69C-0264CA3B25EFQ38912962-A6141049-3BDE-44D2-A713-F3F819C4D56BQ39457954-48630233-CD54-4B6F-A21B-FA6598B6D59AQ39463912-3753D775-78CF-44F3-9381-C37F208D6A28Q51174629-6CF54737-8BDE-44BF-AB62-27C169DFD0C5Q52026564-793CC0B0-1B6A-4BAF-A24B-1360C48819CA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The discrepancy in discrepant analysis.
@en
The discrepancy in discrepant analysis.
@nl
type
label
The discrepancy in discrepant analysis.
@en
The discrepancy in discrepant analysis.
@nl
prefLabel
The discrepancy in discrepant analysis.
@en
The discrepancy in discrepant analysis.
@nl
P1433
P1476
The discrepancy in discrepant analysis.
@en
P2093
P304
P356
10.1016/S0140-6736(96)05122-7
P407
P577
1996-08-01T00:00:00Z